ANI Pharmaceuticals Inc (NASDAQ:ANIP)
| 55.97 Data as of Jan 30 |  -1.83 / -3.17%Today’s Change | 19.51 Today|||52-Week Range 61.43 | -0.74% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2010 | 2011 | 2012 | 2013 | |||
| Revenue and Income | Net Revenues | 2.5M | 435.2K | 2.3M | 30.1M | |
| Cost of Goods Sold | 268.8K | 50.0K | 95.0K | 10.0M | ||
| Depreciation And Amortization | 168.0K | 148.2K | 258.9K | 1.1M | ||
| Operating Expenses | Gross Income | 2.0M | 236.9K | 1.9M | 19.0M | |
| General Expenses | 45.6M | 51.2M | 24.2M | 12.6M | ||
| Research And Development | 39.7M | 44.2M | 16.0M | 1.7M | ||
| Total Operating Expenses | 46.1M | 51.4M | 24.5M | 23.7M | ||
| Non-Operating Expenses | Operating Income | -43.6M | -50.9M | -22.2M | 6.4M | |
| Extraordinary Charge | -2.2M | -23.4K | -5.3M | -6.2M | ||
| Interest Expense On Debt | 688.1K | 681.6K | 348.0K | 167.0K | ||
| Other Expenses | 244.5K | 15.0K | 0.00 | 95.0K | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -46.2M | -51.6M | -27.8M | 126.0K | |
| Income Taxes | 0.00 | 0.00 | -121.8K | -20.0K | ||
| Preferred Dividend | 0.00 | 0.00 | 0.00 | -5.0M | ||
| Discontinued Operations | 0.00 | 0.00 | 0.00 | 195.0K | ||
| Net Income | -46.2M | -51.6M | -27.7M | 301.0K | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 1.8M | 2.7M | 3.6M | 5.1M | |
| Shares To Calculate EPS Diluted | 1.8M | 2.7M | 3.6M | 5.1M | ||
| Earnings Per Share | EPS | -$25.20 | -$18.72 | -$7.62 | -$0.92 | |
| EPS Diluted | -$25.20 | -$18.72 | -$7.62 | -$0.92 | ||
.